Keiji Sakamoto

Simple prediction tools for disease progression in unvaccinated patients with mild/moderate COVID-19 aged under 65 years: Simplified DOATS and DOAT scores

Yoko Shibata, Hiroyuki Minemura, Yasuhito Suzuki, Takefumi Nikaido et autres

jp (code pays fourni par la source)

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19

Yoko Shibata, Kenji Omae, Hiroyuki Minemura, Yasuhito Suzuki et autres

BACKGROUND: During the fifth wave of the coronavirus disease 2019 (COVID-19) pandemic in Japan, which took place between June and September 2021, a significant number of COVID-19 cases with deterioration occurred in unvaccinated individuals < 65 years old. However, the risk factors …

jp (code pays fourni par la source)

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic

Yasuhito Suzuki, Yoko Shibata, Hiroyuki Minemura, Takefumi Nikaido et autres

It is unclear whether molnupiravir has a beneficial effect on vaccinated patients infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We here evaluated the efficacy of molnupiravir in patients with mild-to-moderate coronavirus disease 2019 (COVID-19) during the …

jp (code pays fourni par la source)

Real-world clinical outcomes of treatment with molnupiravir for patients with mild- to-moderate coronavirus disease 2019 during the Omicron variant pandemic

Yasuhito Suzuki, Yoko Shibata, Hiroyuki Minemura, Takefumi Nikaido et autres

Abstract Background It is unclear whether molnupiravir has a beneficial effect on vaccinated patients infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We here evaluated the efficacy of molnupiravir in patients with mild-to-moderate coronavirus disease 2019 (COVID-19) …

jp (code pays fourni par la source)

Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic

Yasuhito Suzuki, Yoko Shibata, Hiroyuki Minemura, Takefumi Nikaido et autres

Background: Mutations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may reduce the efficacy of neutralizing monoclonal antibody therapy against coronavirus disease 2019 (COVID-19).We here evaluated the efficacy of casirivimab-imdevimab in patients with mild-to-moderate COVID-19 during the Delta variant surge in Fukushima …

jp (code pays fourni par la source)

Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic

Yasuhito Suzuki, Yoko Shibata, Hiroyuki Minemura, Takefumi Nikaido et autres

Abstract Background Mutations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may reduce the efficacy of neutralizing monoclonal antibody therapy against coronavirus disease 2019 (COVID-19). We here evaluated the efficacy of casirivimab-imdevimab in patients with mild-to-moderate COVID-19 during the Delta variant surge …

jp (code pays fourni par la source)

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19

Yoko Shibata, Hiroyuki Minemura, Yasuhito Suzuki, Takefumi Nikaido et autres

ABSTRACT BACKGROUND Due to the dissemination of vaccination against severe acute respiratory syndrome coronavirus 2 in the elderly, the virus-susceptible subjects have shifted to unvaccinated non-elderlies. The risk factors of COVID-19 deterioration in non-elderly patients without respiratory failure have not yet been …

jp (code pays fourni par la source)

Intravascular ultrasound imaging of isolated and non aorto-ostial coronary Takayasu arteritis: a case report

Takeshi Shimizu, Akihiko Sato, Keiji Sakamoto, Yoshitane Seino et autres

BACKGROUND: Isolated coronary Takayasu arteritis is a rare form of ischemic heart disease that typically appears as an aorto-ostial lesion. Although several vascular imaging modalities including ultrasonography, computed tomographic angiography, magnetic resonance angiography or catheter angiography, play crucial roles for diagnosing Takayasu …

jp (code pays fourni par la source)

A Novel Hematopoietic Progenitor Cell Mobilization Regimen Comprising Bortezomib, G-CSF, and Preemptive Plerixafor for Multiple Myeloma

Kazuki Tanimoto, Keiji Sakamoto, Ichiro Kawano, Ikumi Yamanaka et autres

Adequate hematopoietic progenitor cell collection is critical for autologous peripheral blood stem cell transplantation.Conventionally, patients with multiple myeloma are treated with high-dose cyclophosphamide and granulocyte colony-stimulating factor(G-CSF)or G-CSF alone to mobilize their peripheral blood stem cells.However, some patients exhibit insufficient stem cell …

jp (code pays fourni par la source)

Hemorrhagic cystitis during chemotherapy for malignant lymphoma patients

Keiji Sakamoto

Quadricuspid pulmonary valve stenosis treated by transcatheter pulmonary valvuloplasty with inoue balloon catheter

Takeshi Shimizu, Norio Tada, Yuji Nozaki, Shohei Ichimura et autres

jp (code pays fourni par la source)

Short-term outcome of percutaneous coronary intervention with directional coronary atherectomy followed by drug-coated balloon: a preliminary report

Akihiko Sato, Mikihiro Kijima, Shohei Ichimura, Daiki Yaegashi et autres

Directional coronary atherectomy (DCA) is a unique technique used in percutaneous coronary intervention (PCI) which involves the removal of plaque from the coronary artery. Treatment with a drug-coated balloon (DCB) appears to be effective, especially when a predilatation of the lesion is …

jp (code pays fourni par la source)